First European Case of TAFRO Syndrome Associated with Sjogren Disease
American Journal of Internal Medicine
Volume 2, Issue 6, November 2014, Pages: 102-105
Received: Jul. 3, 2014; Accepted: Nov. 5, 2014; Published: Nov. 20, 2014
Views 2940      Downloads 198
Authors
Lynn Antoun Abdo, Internal medicine department, Saint Antoine Hospital, Paris, France
Clement Philippe Morin, Internal medicine department, Saint Camille Hospital, Bry-sur-Marne, France
Rocco Paolo Collarino, Infectious disease department, Tenon hospital, Paris, France
Jean Paul Cabane, Internal medicine department, Saint Antoine Hospital, Paris, France
Marc Albert Gatfosse, Internal medicine department, Saint Antoine Hospital, Paris, France
Article Tools
Follow on us
Abstract
We herein describe a case of an unusual multicentric castleman disease(MCD) accompanied by Thrombocytopenia, Anasarca, myeloFibrosis and Renal failure, compatible with TAFRO syndrome and associated with Sjogren disease. The treatment with corticosteroids dramatically improved the symptoms. The clinical features of this case were similar to those reported previously in Japan but this appears to be the first European MCD with negative HHV8 and HIV that meets the criteria of TAFRO syndrome, associated with Sjögren disease.
Keywords
TAFRO Syndrome, Sjogren Disease, Castleman Disease, Interleukin-6, Thrombocytopenia, Pleural Effusion
To cite this article
Lynn Antoun Abdo, Clement Philippe Morin, Rocco Paolo Collarino, Jean Paul Cabane, Marc Albert Gatfosse, First European Case of TAFRO Syndrome Associated with Sjogren Disease, American Journal of Internal Medicine. Vol. 2, No. 6, 2014, pp. 102-105. doi: 10.11648/j.ajim.20140206.12
References
[1]
Takai K, Nikkuni K, Shibuya H, Hashidate H: Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51:320-325, 2010 (in Japanese)
[2]
Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, et al.: Multicentric Castleman's disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus 20:44-50, 2011
[3]
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyper-plasia resembling thymona. Cancer 1956; 9:822-30.
[4]
Frizzera G, Massarelli G, Banks BM, Rosai J: A systemic lym- phoproliferative disorder with morphologic features of Castleman’s disease. Pathological findings in 15 patients. Am J Surg Pathol 7:211-231, 1983
[5]
Muskardin TW, Peterson BA, Molitor JA. Castleman disease and associated autoimmune disease. Curr Opin Rheumatol 24: 76-83, 2012.
[6]
Frizzera G, Peterson BA, Bayrd ED, Goldman A: A systemic lymphoproliferative disorder with morphologic features of Castleman's disease : clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216, 1985
[7]
Keller AR, Hochholzer L, Castleman B: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670-683, 1972
[8]
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, et al.: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280, 1995
[9]
Lui SL, Chan KW, Li FK, et al. Castle-man's disease and mesangial proliferative glomerulonephritis The role of interleukin-6. Nephron 1998;78:323-7.
[10]
Beck JT, Hsu SM, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by momoclonal antiinterleukin-6 antibody. N Engl J Med 1994; 330:602-5.
[11]
Kojima M, Nakamura S, Itoh H, Yoshida K, Asano S, et al.: Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman’s disease : A clinicopatholoic study of five cases. Pathol Res Pract 193:565-571, 1997
[12]
Hattori N, Nakashima H, Usui T, Maeda T, Yanagisawa K, Nakamaki T, Tomoyasu S: Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjögren syndrome. Rinsho Ketsueki. 2007 Dec;48(12):1539-43.
[13]
Ozawa T, Kosugi S, Kito M, Onishi M, Kida T, Nakata S, Take H, Katagiri S: efficacy of ritiximab for TAFRO syndrome, a variant type of multicentric castlemans’s disease Rinsho Ketsueki. 2014 Mar;55(3):350-5.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186